Table: begin end state 1 27 cytoplasmic 28 51 transmembrane 52 66 non-cytoplasmic 67 87 transmembrane 88 98 cytoplasmic 99 119 transmembrane 120 125 non-cytoplasmic 126 151 transmembrane 152 162 cytoplasmic 163 186 transmembrane 187 197 non-cytoplasmic 198 217 transmembrane 218 251 cytoplasmic 252 274 transmembrane 275 292 non-cytoplasmic 293 311 transmembrane 312 318 cytoplasmic 319 338 transmembrane 339 343 non-cytoplasmic 344 367 transmembrane 368 378 cytoplasmic 379 402 transmembrane 403 408 non-cytoplasmic 409 428 transmembrane 429 432 cytoplasmic
Input: >Pf1N1B4_2033 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_2033 MTTAPSSIAQPTQSTRPLTRNDYKTLSLSALGGALEFYDFIIFVFFATVVGKLFFPADMP EWLRLMQTFGIFAAGYLARPLGGIVMAHFGDLLGRKKMFTLSIFMMAVPTLIMGLLPTYA QIGMWAPILLLLMRVIQGAAIGGEVPGAWVFVSEHVPQRHIGYACGTLTSGLTAGILLGS LVATAINSIYTPVEVSDYAWRIPFLLGGVFGLFSVYLRRWLHETPVFAELQLRKALAEEV PLRAVLRDHRGAILISMLLTWLLSAAIVVLILMTPTVLQTVYHFAPTTALQSNSVAIVLL SIGCIIAGALADRFGAGRVFVFGCAALLVSSWTFYHSLAEHPDWLFPMYAITGLLVGTIG AVPYVMVKAFPPVVRFSGLSFSYNVAYAIFGGLTPMIVSLLLKESPMGPAYYVAVLCGVG ILVGAYLWKKGR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server